Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Bristol-Myers Squibb (BMY -5.3%) appears to be on the short end of its toe-to-toe data presentation with Merck (MRK +2.9%) in melanoma at the AACR Annual Meeting in Chicago.

Results from the Phase 3 CheckMate-227 study showed treatment with the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) in first-line advanced non-small cell lung cancer (NSCLC) significantly increased the progression-free survival rate compared to chemo (43% vs. 13%) in patients with high tumor mutational burden (TMB).

The overall response rate in the O/Y group was 45.3% compared to 26.9% for chemo. Overall survival, although preliminary, was also favorably impacted by the O/Y combination.

Merck's data showed the efficacy of KEYTRUDA + chemo regardless of PD-1 status TMB burden.

Previously: Merck's Keytruda shows treatment benefit in late-stage study in advanced melanoma; shares up 1% premarket (April 16)

Source : https://seekingalpha.com/news/3345795-bristol-myers-opdivo-yervoy-combo-beats-chemo-first-line-lung-cancer-shares-5-percent-merck

172
Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:Seeking Alpha

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:RTTNews

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:Yahoo Finance

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:Medical Xpress

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:RTTNews

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:WFMZ-TV

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:4-Traders

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:Seeking Alpha

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:Yahoo Finance

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows

Source:4-Traders

Keytruda Beats Chemo At Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows